Telephone Follow-Up Effective for Stage I Endometrial Cancer

This article originally appeared here.
Share this content:
Telephone Follow-Up Effective for Stage I Endometrial Cancer
Telephone Follow-Up Effective for Stage I Endometrial Cancer

FRIDAY, April 15, 2016 (HealthDay News) -- For women treated for stage I endometrial cancer, telephone follow-up (TFU) is noninferior to hospital-based follow-up (HFU), according to a study published online April 7 in BJOG: An International Journal of Obstetrics and Gynaecology.

Kinta Beaver, Ph.D., from the University of Central Lancashire in the United Kingdom, and colleagues conducted a randomized, noninferiority trial involving 259 women treated for stage I endometrial cancer. Participants were randomized to receive traditional HFU or nurse-led TFU.

The researchers found that the groups had similar State Trait Anxiety Inventory scores after randomization, with an estimated between-group difference of 0.7 (95 percent confidence interval, −1.9 to 3.3, with the confidence interval above the noninferiority limit of −3.5, indicating non-inferiority). Reported satisfaction with information did not differ significantly between the groups (odds ratio, 0.9; 95 percent confidence interval, 0.4 to 2.1). The HFU group was more likely to report being kept waiting for their appointment and not needing any information; they were also less likely to report that the nurse knew about their specific case.

"The TFU provides an effective alternative to HFU for patients with stage I endometrial cancer, with no reported physical or psychological detriment," the authors write. "Patient satisfaction with information was high, with similar levels between groups."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »